NCT00030212View on ClinicalTrials.gov

Immune Abnormalities in Sporadic Inclusion Body Myositis

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 4, 2002

Study Completion Date

December 10, 2007

Conditions
SporadicInclusion BodyMyositis
Trial Locations (2)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

19107-6541

Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00030212 - Immune Abnormalities in Sporadic Inclusion Body Myositis | Biotech Hunter | Biotech Hunter